John Newman

Jonathan Miller

Philip Nadeau

Tommie Reerink

- **Greg Ciongoli** has been appointed **Chair of the Board of Directors** at Atara Biotherapeutics and will also serve on the Nominating and Corporate Governance Committee.  **[1604464_993d9463ed5b443596315b51e5a44f23_0]** 
- **Pascal Touchon**, **Maria Grazia Roncarolo, M.D.**, and **Ameet Mallik** are stepping down from the Board of Directors.  **[1604464_993d9463ed5b443596315b51e5a44f23_0]** 
- These board changes are intended to reflect Atara's **reduced company size** and to **right-size the board** in line with its smaller footprint.  **[1604464_993d9463ed5b443596315b51e5a44f23_0]** 
- The company is positioned to consider value-maximizing options for its Ebvallo milestones and royalties, and its allogeneic CAR T portfolio, following the **FDA's acceptance of the resubmitted BLA** and **reduced operating costs**.  **[1604464_993d9463ed5b443596315b51e5a44f23_0]**

Atara Biotherapeutics (ATRA)